Gene therapy loses luster as investors eye quicker returns from weight-loss drugs
In the last year, some drugmakers have pulled back from the sector, including Pfizer, which recently stopped selling its gene ...
Food Safety News12h
FDA puts food safety rule on hold
The FDA is delaying enforcement of the Food Traceability Rule, which has been in the works for 14 years, by another 30 months ...
The rising cost of prescription drugs in America: Can discount cards provide relief
SaveHealth reports on the third-party companies that work to negotiate discounts with pharmacies and pharmacy benefit ...
Creative Medical secures FDA clearance for dose escalation in Phase 1/2 trial
Creative Medical Technology Holdings announced that the U.S. Food and Drug Administration has cleared an expanded dose escalation for its ongoing Phase 1/2 trial of StemSpine usin ...
This cutting edge hair loss treatment is a repurposed drug from the 1990s
Rogaine was approved by the Food and Drug Administration in 1988, the first drug to win the agency’s endorsement for male ...
BenefitsPRO2d
JPMorgan sued by employees over alleged inflated drug prices
Current and former employees are suing JPMorgan, alleging that it allows inflated drug prices through its partnership with ...
Patient dies following muscular dystrophy gene therapy, Sarepta reports
The young man died of acute liver injury, a known side effect, Sarepta said in a statement. But the company said the “severity” of the patient’s case had not previously been seen with the therapy, ...
GlobeSt3d
Life Sciences Sector Confronts Patent Expirations, Supply Chain Risks, and Regulatory Uncertainty
The life sciences are experiencing a shifting landscape of rapid technological innovation and volatile market conditions that companies in the sector must be ready to adapt to, according to a new ...
Digital therapists get stressed too, study finds
And when chatbots get stressed out, they are less likely to be useful in therapeutic settings with people. The bot’s anxiety ...
Some Philly patients worry about affording their medications as insurers cut coverage for weight-loss drugs
The exorbitant costs of drugs like Wegovy — especially compared to other countries — have prompted some insurers to tighten ...
The cost of insurance cuts | Morning Newsletter
Philly patients worry about affording their weight-loss medications as some insurers tighten requirements around coverage. Plus, New Jersey may bring back cursive requirements in schools.